Amgen Says Aimovig & Amjevita To Be Available At Discounted Monthly Price Of $299 Under Deal With U.S. Govt
ReutersDec 19, 2025 7:58 PM
Dec 19 (Reuters) - Amgen Inc AMGN.O:
AMGEN TAKES ACTION WITH THE U.S. GOVERNMENT TO LOWER THE COST OF MEDICINES FOR AMERICAN PATIENTS
AMGEN INC - INVESTED OVER $40 BILLION IN MANUFACTURING AND RESEARCH AND DEVELOPMENT SINCE 2018
AMGEN INC - EXPAND ITS DIRECT-TO-PATIENT PROGRAM, AMGENNOW™ TO INCLUDE AIMOVIG(®) (ERENUMAB-AOOE) AND AMJEVITA(®) (ADALIMUMAB-ATTO)
AMGEN INC: ALL THREE MEDICINES WILL ALSO BE OFFERED THROUGH TRUMPRX.GOV.
AMGEN INC: AIMOVIG & AMJEVITA WILL BE AVAILABLE AT A DISCOUNTED MONTHLY PRICE OF $299
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey
Related Articles
TradingKey 2025 Markets Recap & Outlook | Bitcoin Price Repeatedly Hits New Highs, 2026 Can BTC Write Another Legend?
Multiple tailwinds in 2025 propelled Bitcoin to new highs, but many of these positives have already been priced in. In 2026, Bitcoin faces challenges such as liquidity tightening, as well as regulatory and monetary policy uncertainties. Wall Street is divided on Bitcoin's future outlook, with targetTradingKey
4 hours ago
TradingKey 2025 Markets Recap & Outlook | Global Central Banks 2026 amid Post‑Easing Recovery and Diverging Paths
TradingKey - In 2025, major global central banks will largely maintain an accommodative stance, but the policy pace will decelerate notably. As the easing cycle draws to a close, how will global monetary policy evolve?TradingKey
23 hours ago
Ripple Price Prediction: Why Is XRP Price Falling? Can It Rise to $10 in the Future?
XRP has weakened this year due to profit-taking, capital outflows, and its correlation with Bitcoin. Despite support from potential spot ETFs and positive regulatory developments, significant market divergence, liquidity uncertainty, and macroeconomic uncertainty remain high. XRP's price is likely tTradingKey
Wed, Dec 24
Elon Musk’s SpaceX Poised for Record-Breaking IPO: How Can Retail Investors Get In on the Action of Starlink Stock?
TradingKey - Elon Musk's rocket manufacturer SpaceX is expected to launch an IPO in 2026, with a target IPO valuation projected to reach $1.5 trillion. However, prior to its listing, the stock can only be traded in the private market, characterized by low information transparency and high capital baTradingKey
Fri, Dec 19
Tradingkey
